In consultation: Guidance and quality standards

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Consultation end date

Consultation end date

Type

Guidance programme

Guidance programme

HealthTech approach

HealthTech approach

Showing 21 to 24 of 24

TitleConsultationTypeConsultation end date
Zanidatamab with chemotherapy with or without tislelizumab for untreated HER2-positive unresectable advanced gastro-oesophageal adenocarcinoma ID6672Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Ex-situ machine perfusion devices to preserve deceased donor livers for transplantationDraft guidanceHealth technology evaluation
Neurostimulation of lumbar muscles for refractory non-specific chronic low back painDraft scope consultationHealthTech guidance
Atogepant for treating migraine [ID6615]Final draft guidanceTechnology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All